Product
Supplier
Encyclopedia
Inquiry
Home > Encyclopedia > Niflumic acid

Niflumic acid

pharmaceutical raw materials
Niflumic acid structure

Niflumic acid 

structure
  • CAS No:

    4394-00-7

  • Formula:

    C13H9F3N2O2

  • Chemical Name:

    Niflumic acid

  • Synonyms:

    3-Pyridinecarboxylic acid,2-[[3-(trifluoromethyl)phenyl]amino]-;Nicotinic acid,2-(α,α,α-trifluoro-m-toluidino)-;2-[[3-(Trifluoromethyl)phenyl]amino]-3-pyridinecarboxylic acid;UP 83;Niflumic acid;2-[3-(Trifluoromethyl)anilino]nicotinic acid;Nifluril;Actol (analgesic);Actol;Nifluminic acid;Flogovital;Forenol;Landruma;Donalgin;2-[3-(Trifluoromethyl)anilino]-3-pyridinecarboxylic acid;N-(α,α,α-Trifluoro-m-tolyl)nicotinic acid;Niflamol

  • Categories:

    Active Pharmaceutical Ingredients  >  Antipyretic Analgesics

Description

Niflumic acid, a Ca2+-activated Cl- channel blocker, is an analgesic and anti-inflammatory agent used in the treatment of rheumatoid arthritis.Target: Othersniflumic acid, an inhibitor of calcium-activated chloride currents. Niflumic acid does not block directly calcium channels or activate potassium channels. Niflumic acid selectively reduces a component of noradrenaline- and 5-HT-induced pressor responses by inhibiting a mechanism which leads to the opening of voltage-gated calcium cha


Solid


Niflumic acid is an aromatic carboxylic acid and a member of pyridines.|Niflumic acid is an analgesic and anti-inflammatory agent used in the treatment of rheumatoid arthritis.|An analgesic and anti-inflammatory agent used in the treatment of rheumatoid arthritis.

Niflumic acid Basic Attributes

282.22

282.22

224-516-2

4U5MP5IUD8

758196

DTXSID1023368

M02AA17|M - Musculo-skeletal system

2933399090

Characteristics

62.2

3.7

Solid

1.4±0.1 g/cm3

204 °C

378°C at 760 mmHg

182.4±27.9 °C

1.589

soluble in ethanol (~50 mg/ml), acetone (50 mg/ml, Clear to Slightly Hazy, Yellow), methanol (~50 mg/ml), DMSO (56 mg/ml at 25°C), and acetonitrile (~50 mg/ml).

Store at RT

LD50 in rats (mg/kg): 370 orally; 155 i.p. (Sorenson)

159.4 Ų [M+H]+ [CCS Type: TW, Method: calibrated with polyalanine and drug standards]|156.8 Ų [M+H]+ [CCS Type: TW]

Safety Information

6.1

UN 2811 6.1/PG 3

3

20/21/22-36/37/38

26-36-36/37/39

QT2999100

Xn

Stable, but may discolour in light. Incompatible with strong oxidizing agents. Hygroscopic.

P261-P280-P301 + P312 + P330-P305 + P351 + P338

H302 + H312 + H332-H315-H319-H335

|Warning|H302 (93.33%): Harmful if swallowed [Warning Acute toxicity, oral]|P261, P264, P270, P271, P280, P301+P312, P302+P352, P304+P312, P304+P340, P305+P351+P338, P312, P321, P322, P330, P332+P313, P337+P313, P362, P363, P403+P233, P405, and P501|Aggregated GHS information provided by 45 companies from 6 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

Toxicity

Oral, mouse: LD50 = 350 mg/kg; Oral, rat: LD50 = 250 mg/kg

90% bound to plasma proteins.

Drug Information

Used in the treatment of rheumatoid arthritis.

Niflumic acid, a nonsteroidal anti-inflammatory fenamate, is a Ca2+-activated Cl- channel blocker.

Compounds or agents that combine with cyclooxygenase (PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES) and thereby prevent its substrate-enzyme combination with arachidonic acid and the formation of eicosanoids, prostaglandins, and thromboxanes. (See all compounds classified as Cyclooxygenase Inhibitors.)|Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions.They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects. (See all compounds classified as Anti-Inflammatory Agents, Non-Steroidal.)

Well absorbed following oral administration.

Hepatic.

2.5 hours

Niflumic acid is able to inhibit both phospholipase A2 as well as COX-2, thereby acting as an antiinflamatory and pain reduction agent.

Acid, Niflumic

Niflumic acid Use and Manufacturing

Uses

Anti-inflammatory. Selective cyclooxygenase-2 (COX-2) inhibitor

Pharmaceuticals

Computed Properties

Molecular Weight:282.22
XLogP3:3.7
Hydrogen Bond Donor Count:2
Hydrogen Bond Acceptor Count:7
Rotatable Bond Count:3
Exact Mass:282.06161202
Monoisotopic Mass:282.06161202
Topological Polar Surface Area:62.2
Heavy Atom Count:20
Complexity:349
Covalently-Bonded Unit Count:1
Compound Is Canonicalized:Yes

Recommended Suppliers of Niflumic acid

Scan the QR Code to Share

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.